Chinese herbal products for female infertility in Taiwan: A population-based cohort study

Medicine (United States)

Volumn 95, Issue 11, 2016, Pages

  Hung, Yu Chiang ^a,b   Kao, Chao Wei ^a   Lin, Che Chen ^c   Liao, Yen Nung ^a   Wu, Bei Yu ^a   Hung, I Ling ^a   Hu, Wen Long ^a,d,e  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b IShou University   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d FOOYIN UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DANG GUI SHA YAO SAN; GUI PI TANG; GUI ZHI FU LING WAN; HERBACEOUS AGENT; JIA WEI XIAO YAO SAN; SHAO FU ZHU YU TANG; SHEN LING BAI ZHU SAN; SI WU TANG; UNCLASSIFIED DRUG; WEN JING TANG; YOU GUI WAN; ZOU GUI WAN;

ADULT; ARTICLE; CHINESE HERB; CHINESE MEDICINE; CUSCUTA; CYPERUS ROTUNDUS; DIPSACUS; DIPSACUS ASPER; ECLIPTA PROSTRATA; ENDOMETRIOSIS; EPIMEDIUM BREVICORNUM; EUCOMMIA ULMOIDES; FEMALE; FEMALE INFERTILITY; FRUCTUS LIGUSTRI LUCIDI; HERBAL MEDICINE; HUMAN; LEONURUS; LEONURUS JAPONICUS; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; MORINDA OFFICINALIS; OVARY POLYCYSTIC DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SALVIA MILTIORRHIZA; SEMEN CUSCUTAE; TAIWAN; UTERUS MYOMA; COHORT ANALYSIS; INFERTILITY, FEMALE; PHYTOTHERAPY;

ADULT; COHORT STUDIES; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INFERTILITY, FEMALE; PHYTOTHERAPY;

EID: 84962007056     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003075     Document Type: Article

References (38)

1. Mascarenhas MN, Flaxman SR, Boerma T, et al. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9:e1001356.
2. Department of Household Registration Affairs, Ministry of Interior. Fertility Rates of Childbearing Age Women. Available at: http:// sowf.moi.gov.tw/stat/year/y02-04.xls. Accessed Jun 1, 2015.
3. Rodriguez D. Female fertility: a conceptual and dimensional analysis. J Midwifery Womens Health. 2013;58:182-128.
4. Gurunath S, Pandian Z, Anderson RA, et al. Defining infertility: a systematic review of prevalence studies. Hum Reprod Update. 2011;17:575-588.
5. Juul S, Karmaus W, Olsen J. Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group. Hum Reprod. 1999;14:1250-1254.
6. Olsen J, Küppers-Chinnow M, Spinelli A. Seeking medical help for subfecundity: a study based upon surveys in five European countries. Fertil Steril. 1996;66:95-100.
7. Meng QQ, Zhang YL, Ren AG. Infertility rate in married couples of reproductive age in China: a systematic review and meta-analysis. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34:826-831.
8. Weeg N, Shalom-Paz E, Wiser A. Age and infertility: the clinical point of view. Minerva Ginecol. 2012;64:477-483.
9. American College of Obstetricians, Gynecologists Committee on Gynecologic Practice, Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014;101:633-634.
10. Rutstein SO, Shah IH. Infecundity, infertility, and childlessness in developing countries. DHS Comparative Reports No. 9. Calverton, MD: ORC Macro and the World Health Organization, 2004.
11. De Berardis D, Mazza M, Marini S, et al. Psychopathology, emotional aspects and psychological counselling in infertility: a review. Clin Ter. 2014;165:163-169.
12. Rouchou B. Consequences of infertility in developing countries. Perspect Public Health. 2013;133:174-179.
13. Dyer SJ, Patel M. The economic impact of infertility on women in developing countries: a systematic review. Facts Views Vis Obgyn. 2012;4:102-109.
14. Abrao MS, Muzii L, Marana R. Anatomical causes of female infertility and their management. Int J Gynaecol Obstet. 2013;123:S18-24.
15. WHO Technical Report Series. Recent Advances in Medically Assisted Conception Number 820, 1992, 1-111.
16. Weiss RV, Clapauch R. Female infertility of endocrine origin. Arq Bras Endocrinol Metabol. 2014;58:144-152.
17. Stanford JB, Martin JC, Gibson M, et al. Use of clomiphene citrate in the University of Utah Community Clinics. J Reprod Med. 2013;58:229-233.
18. Diergaarde B, Kurta ML. Use of fertility drugs and risk of ovarian cancer. Curr Opin Obstet Gynecol. 2014;26:125-129.
19. Riskin-Mashiah S. Infertility, fertility treatment and breast cancer risk. Harefuah. 2013;152:600-604.
20. Gadducci A, Guerrieri ME, Genazzani AR. Fertility drug use and risk of ovarian tumors: a debated clinical challenge. Gynecol Endocrinol. 2013;29:30-35.
21. Storeng R, Vangen S, Omland AK, et al. Infertility treatment and the risk of cancer. Tidsskr Nor Laegeforen. 2012;132:2494-2499.
22. Vlahos NF, Economopoulos KP, Creatsas G. Fertility drugs and ovarian cancer risk: a critical review of the literature. Ann N Y Acad Sci. 2010;1205:214-219.
23. Armstrong S, Akande V. What is the best treatment option for infertile women aged 40 and over? J Assist Reprod Genet. 2013;30:667-671.
24. Chang LC, Huang N, Chou YJ, et al. Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv Res. 2008; 8:170.
25. Chen FP, Chen TJ, Kung YY, et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res. 2007;7: 26.
26. Hung YC, Tseng YJ, Hu WL, et al. Demographic and prescribing patterns of Chinese herbal products for individualized therapy for ischemic heart disease in Taiwan: population-based study. PLoS One. 2015;10:e0137058.
27. Tan L, Tong Y, Sze SC, et al. Chinese herbal medicine for infertility with anovulation: a systematic review. J Altern Complement Med. 2012;18:1087-1100.
28. See CJ, McCulloch M, Smikle C, et al. Chinese herbal medicine and clomiphene citrate for anovulation: a meta-analysis of randomized controlled trials. J Altern Complement Med. 2011;17: 397-405.
29. Chen HY, Lin YH, Wu JC, et al. Characteristics of pediatric traditional Chinese medicine users in Taiwan: a nationwide cohort study. Pediatrics. 2012;129:e1485-1492.
30. Usuki S, Higa TN, Soreya K. The improvement of luteal insufficiency in fecund women by tokishakuyakusan treatment. Am J Chin Med. 2002;30:327-338.
31. Usuki S, Kotani E. Tokishakuyakusan directly attenuates PACAP's luteolytic action on luteal function in the rat ovary. Am J Chin Med. 2002;30:521-531.
32. Shen AY, Wang TS, Huang MH, et al. Antioxidant and antiplatelet effects of dang-gui-shao-yao-san on human blood cells. Am J Chin Med. 2005;33:747-758.
33. Hsu CS, Yang JK, Yang LL. Effect of "Dang-Qui-Shao-Yao-San" a Chinese medicinal prescription for dysmenorrhea on uterus contractility in vitro. Phytomedicine. 2006;13:94-100.
34. Ke J, Duan R. Effects of flavonoids from semen cuscutae on the hippocampal-hypothalamic-pituitary-ovarian sex hormone receptors in female rats exposed to psychological stress. Clin Exp Obstet Gynecol. 2013;40:271-274.
35. Ma HX, You ZL, Wang XY. Effect of total flavones from Cuscuta chinensis on expression of Fas/FasL, PCNA and HB-EGF in SD rats model with bromocriptine-induced abortion. Zhong Yao Cai. 2008;31:1706-1709.
36. Ushiroyama T, Hosotani T, Mori K, et al. Effects of switching to wen-jing-tang (unkei-to) from preceding herbal preparations selected by eight-principle pattern identification on endocrinological status and ovulatory induction in women with polycystic ovary syndrome. Am J Chin Med. 2006;34:177-187.
37. Hsu CS, Yang JK, Yang LL. Effect of a dysmenorrhea Chinese medicinal prescription on uterus contractility in vitro. Phytother Res. 2003;17:778-783.
38. Shang X, Pan H, Wang X, et al. Leonurus japonicus Houtt.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol. 2014;152:14-32.